26Apr 2025
GLP-1 Agonists Aid Pediatric Obesity: Safe, Effective Weight Reduction

GLP-1 Agonists Aid Pediatric Obesity: Safe, Effective Weight Reduction

A meta-analysis of 8 trials involving 715 youth found that GLP-1 receptor agonists significantly reduced BMI (SMD −0.67), body weight (−0.60), and waist circumference (−0.40). While cardiometabolic markers like HbA1c and lipids showed no change, systolic blood pressure declined slightly. Side effects, mostly mild GI issues, were more frequent but rarely led to withdrawal.

  • #endo-diabetology

Like

Save

Share